Research On Optimization Of Funding Strategy Of S Pharmaceutical Company

At present,factors such as the continuous increase in the income level of our residents,the continuous growth of the population,the continuous reform of social medical insurance and health systems,and the continuous aging of the population will all stimulate the development of the domestic pharmaceutical market for a long time.The internal reorganization and integration of the industry,the reshaping of the pharmaceutical industry,and the increasing competition are both opportunities and challenges for pharmaceutical manufacturing companies.Funds are an important guarantee for enterprises to seize the opportunity for rapid development and increase scientific research and innovation to maintain their competitive advantage.Faced with capital needs,what kind of fund-raising strategy to adopt and how to carry out fund-raising planning are the focus of this article.This article takes S Pharmaceutical Company as the research object.The pharmaceutical manufacturing industry of S Pharmaceutical Company has formed a full-chain industry integration with the company's development and growth.In the current industry background,in order to further promote the industrial layout and maintain the competitive advantage,S pharmaceutical company must invest a lot of money to maintain the company's operation.How to ensure the company's smooth access to funds is crucial.This article first analyzes the internal and external financing environment of S Pharmaceutical Company.In terms of external financing environment: the monetary policy is moderately tight and the industry provides certain policy support,etc.,which alleviates the difficulty of financing to a certain extent.The internal financing environment starts from four aspects: profitability,solvency,operating ability,and growth ability.It uses financial index analysis,trend analysis and other analytical methods to deeply analyze the company's profitability,development ability,and debt repayment ability.It will have an important impact on the company's subsequent refinancing ability.The financing strategy adopted by the enterprise will be fully reflected in its financial data and financial structure.Therefore,through in-depth analysis of the retained earnings scale,debt internal structure,asset-liability structure,and interest-bearing debt scale of S Pharmaceutical Company,the following problems were found: First,the internal financing channel is unstable,and he internal financing ability is weak;Second,The capital market is not fully utilized and the financing channels are relatively single.;Third,the debt structure is unbalanced and the financial risks are large.;Fourth,the financing period is not matched,and the source of funds is weak;Fifth,the financing strategy is aggressive and inconsistent with industry characteristics.In this paper,in view of the above problems and the internal and external development status of S pharmaceutical company,the current financing strategy of S pharmaceutical company is optimized,and it is proposed that S pharmaceutical company is suitable for adopting a stable financing strategy.By analyzing the company's funding motivation,reasonably predicting the amount of funds required,studying the funding channels that the company can adopt,it proposes a variety of funding matching methods,and analyzes the applicability of each method,selecting a funding optimization plan suitable for S Pharmaceutical Company,and finally based on The plan proposes corresponding safeguards.Maintain the current good development trend and continue to strengthen cost control to improve profit retention and refinancing capabilities;set up a professional fund management team,improve the fund management system,further refine the fundraising plan,and improve the operability;Maintain good bank-enterprise relations and solidify existing financing channels.